Literature DB >> 11823365

Chronic aspirin is effective--if data are massaged sufficiently.

John G F Cleland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11823365      PMCID： PMC1122204     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  No reduction in cardiovascular risk with NSAIDs-including aspirin?

Authors:  John G F Cleland
Journal:  Lancet       Date:  2002-01-12       Impact factor: 79.321

2.  Article makes simple errors and could cause unnecessary deaths.

Authors:  Colin Baigent; Rory Collins; Richard Peto
Journal:  BMJ       Date:  2002-01-19

3.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

Review 4.  Is aspirin safe for patients with heart failure?

Authors:  J G Cleland; C J Bulpitt; R H Falk; I N Findlay; C M Oakley; G Murray; P A Poole-Wilson; C R Prentice; G C Sutton
Journal:  Br Heart J       Date:  1995-09

5.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

6.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

7.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.